Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $1.147B (100.0% shares, 0.0% debt)

Holdings (33)

BMRN BIOMARIN PHARMACEUTICAL INC 14.9%
Value $171M Shares 2,061,373 Share Price $82.87 * Est. Cost/Share $83.16 Unrealized @ Report Date -4.3%
UTHR UNITED THERAPEUTICS CORP 13.0%
Value $150M Shares 634,806 Share Price $235.64 * Est. Cost/Share $89.23 Unrealized @ Report Date +127.8%
— ABIOMED INC 10.7%
Value $122M Shares 494,397 Share Price $247.51 Est. Cost/Share $81.43 Unrealized @ Report Date —
INSM INSMED INC 10.0%
Value $115M Shares 5,840,398 Share Price $19.72 * Est. Cost/Share $17.79 Unrealized @ Report Date +17.8%
FOLD AMICUS THERAPEUTICS INC 9.2%
Value $106M Shares 9,847,774 Share Price $10.74 * Est. Cost/Share $9.52 Unrealized @ Report Date -13.5%
STAA STAAR SURGICAL CO 6.8%
Value $78.49M Shares 1,106,567 Share Price $70.93 * Est. Cost/Share $14.28 Unrealized @ Report Date +351.3%
BIIB BIOGEN INC 6.4%
Value $73.62M Shares 360,981 Share Price $203.94 Est. Cost/Share $264.06 Unrealized @ Report Date -22.6%
— REVANCE THERAPEUTICS INC 5.3%
Value $60.88M Shares 4,405,039 Share Price $13.82 Est. Cost/Share $21.99 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 4.0%
Value $45.65M Shares 1,681,477 Share Price $27.15 * Est. Cost/Share $21.46 Unrealized @ Report Date +36.3%
— SAGE THERAPEUTICS INC 2.4%
Value $27.5M Shares 851,409 Share Price $32.30 Est. Cost/Share $46.62 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 2.4%
Value $27.15M Shares 2,491,200 Share Price $10.90 * Est. Cost/Share $11.21 Unrealized @ Report Date -7.6%
— KARYOPHARM THERAPEUTICS INC 2.2%
Value $25.35M Shares 5,621,533 Share Price $4.51 Est. Cost/Share $16.36 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 2.1%
Value $23.65M Shares 1,678,196 Share Price $14.09 * Est. Cost/Share $33.89 Unrealized @ Report Date -44.9%
ALKS ALKERMES PLC 1.6%
Value $17.98M Shares 603,400 Share Price $29.79 * Est. Cost/Share $22.36 Unrealized @ Report Date +28.5%
EHTH EHEALTH INC 1.3%
Value $15.44M Shares 1,654,693 Share Price $9.33 * Est. Cost/Share $59.40 Unrealized @ Report Date -82.9%
GOSS GOSSAMER BIO INC 1.3%
Value $14.65M Shares 1,750,651 Share Price $8.37 * Est. Cost/Share $11.85 Unrealized @ Report Date -34.6%
SNDX SYNDAX PHARMACEUTICALS INC 1.0%
Value $11.79M Shares 612,600 Share Price $19.24 * Est. Cost/Share $16.84 Unrealized @ Report Date -1.1%
ALGN ALIGN TECHNOLOGY INC 0.9%
Value $10.49M Shares 44,305 Share Price $236.68 * Est. Cost/Share $114.31 Unrealized @ Report Date +168.8%
— EPIZYME INC 0.9%
Value $9.959M Shares 6,774,541 Share Price $1.47 Est. Cost/Share $11.87 Unrealized @ Report Date —
ANAB ANAPTYSBIO INC 0.8%
Value $8.75M Shares 431,024 Share Price $20.30 * Est. Cost/Share $19.06 Unrealized @ Report Date +16.2%
— CLOVIS ONCOLOGY INC 0.7%
Value $8.053M Shares 4,473,967 Share Price $1.80 Est. Cost/Share $42.71 Unrealized @ Report Date —
— GRITSTONE ONCOLOGY INC 0.5%
Value $5.64M Shares 2,330,504 Share Price $2.42 Est. Cost/Share $9.42 Unrealized @ Report Date —
— KEZAR LIFE SCIENCES INC 0.5%
Value $5.427M Shares 656,200 Share Price $8.27 Est. Cost/Share $5.16 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.4%
Value $4.389M Shares 111,717 Share Price $39.29 * Est. Cost/Share $6.71 Unrealized @ Report Date +499.7%
TVTX TRAVERE THERAPEUTICS INC 0.4%
Value $4.024M Shares 166,069 Share Price $24.23 * Est. Cost/Share $23.56 Unrealized @ Report Date +6.8%
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value $1.259M Shares 64,700 Share Price $19.46 * Est. Cost/Share $15.56 Unrealized @ Report Date +51.6%
— ALIMERA SCIENCES INC 0.1%
Value $1.099M Shares 200,919 Share Price $5.47 Est. Cost/Share $6.30 Unrealized @ Report Date —
NVAX NOVAVAX INC 0.1%
Value $643K Shares 12,500 Share Price $51.44 Est. Cost/Share $171.82 Unrealized @ Report Date -69.9%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $642K Shares 160,800 Share Price $3.99 * Est. Cost/Share $7.10 Unrealized @ Report Date -51.5%
— MAGENTA THERAPEUTICS INC 0.0%
Value $519K Shares 432,300 Share Price $1.20 Est. Cost/Share $7.38 Unrealized @ Report Date —
URGN UROGEN PHARMA LTD 0.0%
Value $201K Shares 24,500 Share Price $8.20 * Est. Cost/Share $27.01 Unrealized @ Report Date -74.6%
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value $198K Shares 27,100 Share Price $7.31 * Est. Cost/Share $39.74 Unrealized @ Report Date -68.1%
— MARINUS PHARMACEUTICALS INC 0.0%
Value $152K Shares 31,330 Share Price $4.85 Est. Cost/Share $15.48 Unrealized @ Report Date —